6-160500534-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The ENST00000335388.5(LPAL2):n.326+247A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.44 in 152,018 control chromosomes in the GnomAD database, including 16,717 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.44 ( 16717 hom., cov: 32)
Consequence
LPAL2
ENST00000335388.5 intron
ENST00000335388.5 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: -0.0560
Publications
6 publications found
Genes affected
LPAL2 (HGNC:21210): (lipoprotein(a) like 2 (pseudogene)) Apolipoprotein(a) is the distinguishing protein moiety of lipoprotein(a), of which elevated plasma levels are correlated with an increased risk of atherosclerosis. This gene is similar to the lipoprotein, Lp(a) gene, but all transcripts produced by this gene contain a truncated open reading frame and are candidates for nonsense-mediated decay. Consequently, this gene is considered to be a pseudogene. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jul 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.92).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.86 is higher than 0.05.
Transcripts
RefSeq
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| LPAL2 | ENST00000335388.5 | n.326+247A>C | intron_variant | Intron 2 of 9 | 1 | |||||
| LPAL2 | ENST00000435757.6 | n.326+247A>C | intron_variant | Intron 2 of 9 | 1 | |||||
| LPAL2 | ENST00000719163.1 | n.711A>C | non_coding_transcript_exon_variant | Exon 2 of 2 |
Frequencies
GnomAD3 genomes AF: 0.440 AC: 66856AN: 151900Hom.: 16696 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
66856
AN:
151900
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.440 AC: 66904AN: 152018Hom.: 16717 Cov.: 32 AF XY: 0.448 AC XY: 33279AN XY: 74304 show subpopulations
GnomAD4 genome
AF:
AC:
66904
AN:
152018
Hom.:
Cov.:
32
AF XY:
AC XY:
33279
AN XY:
74304
show subpopulations
African (AFR)
AF:
AC:
8845
AN:
41482
American (AMR)
AF:
AC:
8517
AN:
15266
Ashkenazi Jewish (ASJ)
AF:
AC:
1744
AN:
3470
East Asian (EAS)
AF:
AC:
4538
AN:
5148
South Asian (SAS)
AF:
AC:
3189
AN:
4814
European-Finnish (FIN)
AF:
AC:
5079
AN:
10554
Middle Eastern (MID)
AF:
AC:
156
AN:
294
European-Non Finnish (NFE)
AF:
AC:
33358
AN:
67972
Other (OTH)
AF:
AC:
1031
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
1745
3491
5236
6982
8727
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
626
1252
1878
2504
3130
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2624
AN:
3478
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.